Compared with NKG2D CAR-T cells, NKG2D CAR-NK cells eliminated myeloma cells without targeting healthy cells in a mouse model (Leivas et al., 2018; Leivas et al., 2021). The gene discussed is KLRK1; the disease is plasma cell myeloma.